Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$205.26 USD

205.26
632,500

+0.95 (0.46%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $205.49 +0.23 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 11% (28 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why Is Universal Health Services (UHS) Up 9.5% Since Last Earnings Report?

by Zacks Equity Research

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tenet Healthcare (THC) Offers Senior Notes Worth $1.4 B

by Zacks Equity Research

Tenet Healthcare (THC) exhibits prudence by issuing notes to procure funds and pay down its existing debt.

Acadia Healthcare (ACHC) Q1 Earnings Top Estimates, Rise Y/Y

by Zacks Equity Research

Acadia Healthcare (ACHC) Q1 earnings benefit from revenue gains, led by higher revenue per patient day and an increase in patient days, partly offset by a rise in expenses.

Community Health (CYH) Q1 Earnings & Revenues Top Estimates

by Zacks Equity Research

Community Health's (CYH) first-quarter results reflect decline in operating and interest expenses, partly offset by weaker admissions.

Encompass Health (EHC) Q1 Earnings Beat, Hikes '21 View

by Zacks Equity Research

Encompass Health's (EHC) first-quarter results reflect improved Inpatient Rehabilitation segment revenues, partly offset by lower volumes in both its segments and higher costs.

Universal Health (UHS) Q1 Earnings Top, Revenues Improve Y/Y

by Zacks Equity Research

Universal Health's (UHS) first-quarter results highlight uptick in revenues across both the company's segments, partly offset by escalating costs.

Universal Health Services (UHS) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Universal Health Services (UHS) delivered earnings and revenue surprises of 13.49% and 2.75%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Universal Health's (UHS) Q1 Earnings?

by Zacks Equity Research

Universal Health's (UHS) first-quarter earnings are expected to have gained from better revenues and performances by its Acute Care and Behavioral Health segments.

Universal Health Services (UHS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Universal Health (UHS) Ties Up for New Psychiatric Hospital

by Zacks Equity Research

Universal Health's (UHS) affiliate Havenwyck Hospital forms a joint venture with Mercy Heath to construct a new inpatient behavioral health hospital.

Universal Health Services (UHS) Up 0.2% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tenet Healthcare (THC) Hits 52 Week High: Will the Rally Stay?

by Zacks Equity Research

Tenet Healthcare's (THC) shares display an upsurge as investors get optimistic about its latest strategic initiatives and cost-curbing measures.

Here's Why You Should Hold on to Universal Health (UHS) Now

by Zacks Equity Research

Riding high on its solid segments and an impressive top line, Universal Health (UHS) holds enough potential to reap benefits for investors.

Universal Health (UHS) Q4 Earnings Beat, Revenues Up Y/Y

by Zacks Equity Research

Universal Health's (UHS) fourth-quarter results reflect improved revenues across the company's segments, partly offset by elevated costs.

Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.

Acadia Healthcare (ACHC) Q4 Earnings Top Estimates, Rise Y/Y

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q4 results reflect progress in its U.S business, which gained from solid volumes, and its solid cost-management policy.

Universal Health (UHS) to Report Q4 Results: What to Expect?

by Zacks Equity Research

Universal Health's (UHS) fourth-quarter results are likely to reflect gain from better revenues.

Sapna Bagaria headshot

4 Hospital Stocks to Gain From Growth in Patient Admissions

by Sapna Bagaria

Players in the hospital industry are likely to gain from increasing patient admissions, government grants and cost-control measures.

Here's Why You Should Hold MEDNAX (MD) in Your Portfolio Now

by Zacks Equity Research

Riding high on its strategic efforts and cost-cutting measures, MEDNAX (MD) holds enough potential to reap benefits for investors.

Here's Why You Should Bet on Acadia Healthcare (ACHC) Stock

by Zacks Equity Research

Acadia Healthcare (ACHC) has been benefiting from growing demand for behavioral health services, high revenues and solid cash flows.

Here's Why You Should Hold on to Universal Health (UHS) Now

by Zacks Equity Research

Rising high on solid segments and solvency levels, Universal Health (UHS) holds potential to reap benefits for investors.

Enforcement of Price Transparency Rules Puts Hospitals in a Fix

by Zacks Equity Research

Hospital companies might feel the heat from price transparency rules, effective Jan 1, 2021.

Tenet Healthcare (THC) to Rejig Business by Selling Urgent Care

by Zacks Equity Research

Tenet Healthcare (THC) to restructure its ambulatory care business by axing the urgent care business and focusing on growing the ambulatory surgery business.

Is Universal Health (UHS) a Good Value Investor Stock Now?

by Zacks Equity Research

Let's see if Universal Health (UHS) stock is a good choice for value-oriented investors right now from multiple angles.

MEDNAX's (MD) Q3 Earnings Meet Estimates, Revenues Miss

by Zacks Equity Research

MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.